In Brief
Refine Search
Pharmaceutical
UK-based immunotherapy firm Centauri Therapeutics has secured a £1 million ($1.25 million) grant from PACE (Pathways to Antimicrobial Clinical Efficacy) to further develop its Alphamer technology. 25 November 2024
Biotechnology
Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per share in cash. 23 November 2024
Biotechnology
Colorado, USA-based OncoVerity announced the closing of a series A extension led by existing investors, argenX and RefinedScience. The value was not disclosed, but this extension follows a $30 million Series A fundraiser in March 2023. 22 November 2024
Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025. 11 November 2024
Biotechnology
Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity. 4 November 2024
Biotechnology
Japanese drugmaker Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (US brand name Leqembi) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA. 1 November 2024
Pharmaceutical
GSK has announced its largest US manufacturing investment to date, dedicated to producing medicines and vaccines. 25 October 2024
Pharmaceutical
Following a re-examination, the European Medicines Agency’s human health committee, CHMP confirmed its initial recommendation to refuse the granting of a conditional marketing authorization for Masitinib AB Science’s masitinib. 18 October 2024
Pharmaceutical
University Medical Center Groningen (UMCG) and SHINE Europe have secured a 10.5 million euro ($11 million) grant to advance European production of terbium isotopes for cancer treatments. 17 October 2024
Pharmaceutical
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. 15 October 2024
Pharmaceutical
French pharma major Sanofi revealed it has entered into negotiations with private equity firm Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. 14 October 2024
Pharmaceutical
The UK’s new 2024 voluntary scheme for branded medicines pricing, access, and growth (VPAG) came into force at the beginning of January this year. 4 October 2024
Biotechnology
Sirnaomics, a firm specializing in RNAi therapeutics, has entered into a subscription agreement with biotech specialist Poon Hung Fai. 4 October 2024
Biotechnology
GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the US Department of Health and Human Services (HHS). 4 October 2024
Biotechnology
Oxford, UK-based Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. 3 October 2024
Pharmaceutical
French drugmaker Mitem Pharmavhas the worldwide acquisition of Desferal (deferoxamine), a major MITM in hematology, from Swiss giant Novartis. 25 September 2024
article
The European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has elected Bruno Sepodes as its new chair. 19 September 2024
Pharmaceutical
The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million) funding from the German non-profit Boehringer Ingelheim Foundation (BIS). 18 September 2024
Biotechnology
Zenas BioPharma announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. 13 September 2024
Pharmaceutical
October marks the annual Rett Syndrome Awareness Month, a time to examine the support and research being afforded to advance pharmacological treatments for this rare condition. 18 October 2023
Pharmaceutical
Despite statements from international pharmaceutical companies about the suspension of new clinical trials in Russia after February 24, 2022 invasion of Ukraine, the Anglo-Swedish drug major AstraZeneca will conduct a study of a new drug for the prevention of COVID-19 in Russia, reports The Pharma Letter’s local correspondent. 18 October 2023
Biotechnology
US antiviral-focused biotech Assembly Biosciences saw its share price rocket nearly 95% to $1.42, on news of a research collaboration with Gilead Sciences. 17 October 2023
Biotechnology
Spanish genetic medicines company SpliceBio has signed an exclusive collaboration and licensing agreement with Spark Therapeutics, which was acquired by Swiss pharma giant Roche in a $4.8 billion deal in 2020, to utilize SpliceBio’s proprietary Protein Splicing platform to develop a gene therapy for an undisclosed inherited retinal disease. 17 October 2023
Pharmaceutical
A formal disclosure from Aldeyra Therapeutics, suggesting a potential rejection from the US Food and Drug Administration, has stripped around 70% from the firm’s share price. 17 October 2023
Pharmaceutical
US healthcare conglomerate Johnson & Johnson has announced results for third-quarter 2023. 17 October 2023
Biotechnology
In what the company said was a big day for Monte Rosa Therapeutics, a clinical-stage biotech company developing novel molecular glue degrader (MGD)-based medicines, the company announced two major milestones. 17 October 2023
Biotechnology
Chicago, USA-based artificial intelligence and antibody specialist SparX Biopharmaceutical is to embark on a new strategic collaboration with Arovella Therapeutics. 17 October 2023
Biotechnology
Israeli drugmaker Teva Pharmaceutical Industries has announced that data from the UNITE study presented at the World Congress of Neurology in Montreal, Canada, show that Ajovy (fremanezumab) reduced migraine attacks and depression symptoms in migraine patients with major depressive disorder. 17 October 2023
Biotechnology
Seattle, USA-based biotech Omeros Corporation saw its shares plummet as much as 58% to an all-time low of $0.92 yesterday, after it said it will discontinue development of an experimental therapy to treat a type of kidney disease after a late-stage study failure. 17 October 2023
Biotechnology
Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, has emerged from stealth. 17 October 2023
Pharmaceutical
Analysis of American prescribing trends made available by health tech pioneer DrFirst show a six-fold increase in prescriptions written for popular weight loss drug Wegovy (semaglutide) between December 2022 and June 2023. 17 October 2023
Pharmaceutical
Swedish enzyme specialist Hansa Biopharma has announced results from an extended pooled analysis of the 17-HMedIdeS-14 study, testing the antibody-cleaving enzyme imlifidase. 17 October 2023
Pharmaceutical
With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market is expected to grow at a compound annual growth rate (CAGR) of 5.2% from $31.9 billion in 2022 to $53 billion in 2032 across the seven major markets. 17 October 2023
Pharmaceutical
Italian drugmaker Recordati has appointed Milan Zdravkovic as its executive vice president of Research & Development (R&D). 17 October 2023
Pharmaceutical
Danish company Novo Nordisk has agreed to acquire ocedurenone - a drug in development for uncontrolled hypertension with potential application in cardiovascular and kidney disease - from Singapore biotech KBP Biosciences for up to $1.3 billion. 16 October 2023
Biotechnology
A first-of-its-kind, made-in-India product catering to advanced cell-and-gene therapies has been developed in the country. 16 October 2023
Biotechnology
Privately-held, China-based biopharma company EpimAb Biotherapeutics has inked a deal with Spanish Dermatology company Almirall. 16 October 2023
Pharmaceutical
If Ireland’s people were not already somewhat pessimistic on Monday following the country’s exit from the Rugby World Cup, they have further reason for gloom, according to the Irish Pharmaceutical Healthcare Association (IPHA). 16 October 2023
Biotechnology
ZQ Capital Management has made an offer for UK-based Allergy Therapeutics, as required by takeover rules. 16 October 2023
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze